Clinical Trials Directory

Trials / Completed

CompletedNCT01595217

MRCP Diagnoses EHCC Better When Combined DWI

The Incremental Value of 3T Diffusion-Weighted MRI in Diagnosing Extrahepatic Cholangiocarcinoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
99 (actual)
Sponsor
China Medical University, China · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Researching the diagnostic significance of Biliary Tract Neoplasm under combining DWI sequence with MRCP versus MRCP only separately.

Detailed description

The purpose of the study is to evaluate the usefulness of diffusion weighted imaging(DWI) combined with MRCP of 3.0T magnetic resonance imaging (MRI) in the evaluation of suspected malignant bile duct diseases. People with suspected Biliary Tract Neoplasm based on clinical symptoms (such as jaundice and thinness with unknown reasons) and CA-199 value raises are included.Diagnosis divided into two steps: the first one,only provide conventional MR sequences and MRCP images to make a diagnosis; the second step,provide the DWI images additionally, combining the image data before to make a diagnosis. Hypothesis is that DWI sequence should be regularly added into MRCP examination for improving diagnosis rate of Biliary Tract Neoplasm.

Conditions

Interventions

TypeNameDescription
DEVICE3T MRIdiffusion weighted imaging(DWI) of biliary tract with GE Signa 3-tesla device

Timeline

Start date
2012-03-01
Primary completion
2013-03-01
Completion
2013-05-01
First posted
2012-05-09
Last updated
2017-05-16

Locations

1 site across 1 country: China

Regulatory

Source: ClinicalTrials.gov record NCT01595217. Inclusion in this directory is not an endorsement.